Investigational New Drugs,volume 23,issue 5  (10-2014)

Period of time: 2014年5期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 23,issue 5

Menu

Novel therapy in multiple myeloma

By Avilés Agustin,Neri Natividad,Nambo M.,Cleto Sergio,Castañeda Claudia,González Martha,Talavera Alejandra,Huerta-Guzmán Judith in (2005)

Investigational New Drugs,volume 23,issue 5 , Vol. 23, Iss. 5, 2005-10 , pp. 411-415

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists

By Benbrook Doris,Kamelle Scott,Guruswamy Suresh,Lightfoot Stan,Rutledge Teresa,Gould Natalie,Hannafon Bethany,Dunn S.,Berlin K. in (2005)

Investigational New Drugs,volume 23,issue 5 , Vol. 23, Iss. 5, 2005-10 , pp. 417-428

Springer Publishing Company

Abstract Access to resources Recommend Favorite

An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin

By Hirte H.,Stewart D.,Goel R.,Chouinard E.,Huan S.,Stafford S.,Waterfield B.,Matthews S.,Lathia C.,Schwartz B.,Agarwal V.,Humphrey R.,Seymour and in (2005)

Investigational New Drugs,volume 23,issue 5 , Vol. 23, Iss. 5, 2005-10 , pp. 437-443

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer

By Ajani Jaffer,Takimoto Chris,Becerra Carlos,Silva Alejandro,Baez Luis,Cohn Allen,Major Pierre,Kamida Makio,Feit Kevie,Jager Robert in (2005)

Investigational New Drugs,volume 23,issue 5 , Vol. 23, Iss. 5, 2005-10 , pp. 479-484

Springer Publishing Company

Abstract Access to resources Recommend Favorite